These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

553 related articles for article (PubMed ID: 26590574)

  • 1. CD4+ T cells from patients with acute myeloid leukemia inhibit the proliferation of bone marrow-derived mesenchymal stem cells by secretion of miR-10a.
    Yu Z; Li D; Ju XL
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):733-40. PubMed ID: 26590574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-494 Activation Suppresses Bone Marrow Stromal Cell-Mediated Drug Resistance in Acute Myeloid Leukemia Cells.
    Tian C; Zheng G; Zhuang H; Li X; Hu D; Zhu L; Wang T; You MJ; Zhang Y
    J Cell Physiol; 2017 Jun; 232(6):1387-1395. PubMed ID: 27696394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TGF-β1 and CXCL12 modulate proliferation and chemotherapy sensitivity of acute myeloid leukemia cells co-cultured with multipotent mesenchymal stromal cells.
    Schelker RC; Iberl S; Müller G; Hart C; Herr W; Grassinger J
    Hematology; 2018 Jul; 23(6):337-345. PubMed ID: 29140182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes derived from human bone marrow mesenchymal stem cells transfer miR-222-3p to suppress acute myeloid leukemia cell proliferation by targeting IRF2/INPP4B.
    Zhang F; Lu Y; Wang M; Zhu J; Li J; Zhang P; Yuan Y; Zhu F
    Mol Cell Probes; 2020 Jun; 51():101513. PubMed ID: 31968218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exosomes from bone marrow mesenchymal stem cells decrease chemosensitivity of acute myeloid leukemia cells via delivering miR-10a.
    Wu J; Zhang Y; Li X; Ren J; Chen L; Chen J; Cao Y
    Biochem Biophys Res Commun; 2022 Sep; 622():149-156. PubMed ID: 35863089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow miR-10a overexpression is associated with genetic events but not affects clinical outcome in acute myeloid leukemia.
    Zhang TJ; Guo H; Zhou JD; Li XX; Zhang W; Ma JC; Wen XM; Yao XY; Lin J; Qian J
    Pathol Res Pract; 2018 Jan; 214(1):169-173. PubMed ID: 29254789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CXCL8 derived from mesenchymal stromal cells supports survival and proliferation of acute myeloid leukemia cells through the PI3K/AKT pathway.
    Cheng J; Li Y; Liu S; Jiang Y; Ma J; Wan L; Li Q; Pang T
    FASEB J; 2019 Apr; 33(4):4755-4764. PubMed ID: 30592634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone Marrow Mesenchymal Stem Cells-Derived Exosomal miR-425-5p Inhibits Acute Myeloid Leukemia Cell Proliferation, Apoptosis, Invasion and Migration by Targeting WTAP.
    Zhang L; Khadka B; Wu J; Feng Y; Long B; Xiao R; Liu J
    Onco Targets Ther; 2021; 14():4901-4914. PubMed ID: 34594112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DICER1 gene and miRNA dysregulation in mesenchymal stem cells of patients with myelodysplastic syndrome and acute myeloblastic leukemia.
    Ozdogan H; Gur Dedeoglu B; Oztemur Islakoglu Y; Aydos A; Kose S; Atalay A; Yegin ZA; Avcu F; Uckan Cetinkaya D; Ilhan O
    Leuk Res; 2017 Dec; 63():62-71. PubMed ID: 29102598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-10a overexpression is associated with NPM1 mutations and MDM4 downregulation in intermediate-risk acute myeloid leukemia.
    Ovcharenko D; Stölzel F; Poitz D; Fierro F; Schaich M; Neubauer A; Kelnar K; Davison T; Müller-Tidow C; Thiede C; Bornhäuser M; Ehninger G; Brown D; Illmer T
    Exp Hematol; 2011 Oct; 39(10):1030-1042.e7. PubMed ID: 21784052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
    Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
    Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIF-Induced Stromal PKCβ/IL8 Is Essential in Human Acute Myeloid Leukemia.
    Abdul-Aziz AM; Shafat MS; Mehta TK; Di Palma F; Lawes MJ; Rushworth SA; Bowles KM
    Cancer Res; 2017 Jan; 77(2):303-311. PubMed ID: 27872094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bioinformatics Analysis and Verification of Aging-Related Genes of Bone Marrow Mesenchymal Stem Cells in Patients with Acute Myeloid Leukemia].
    Liu SQ; Cheng JY; Jiang YJ; Li Y; Li QH; Pang TX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Apr; 27(2):311-317. PubMed ID: 30998131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA SNHG4 regulates miR-10a/PTEN to inhibit the proliferation of acute myeloid leukemia cells.
    Yuan Z; Wang W
    Hematology; 2020 Dec; 25(1):160-164. PubMed ID: 32319862
    [No Abstract]   [Full Text] [Related]  

  • 15. [Immunomodulatory effects of mesenchymal stem cells derived from the bone marrow in acute leukemia patients].
    Zhao ZG; Sun L; Wang XF; Zhang YZ; Yu Y; Yang HL; Zou P
    Zhonghua Zhong Liu Za Zhi; 2011 Feb; 33(2):105-9. PubMed ID: 21575477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.
    Diaz de la Guardia R; Lopez-Millan B; Lavoie JR; Bueno C; Castaño J; Gómez-Casares M; Vives S; Palomo L; Juan M; Delgado J; Blanco ML; Nomdedeu J; Chaparro A; Fuster JL; Anguita E; Rosu-Myles M; Menéndez P
    Stem Cell Reports; 2017 Jun; 8(6):1573-1586. PubMed ID: 28528702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stromal cells from myelodysplastic and acute myeloid leukemia patients display in vitro reduced proliferative potential and similar capacity to support leukemia cell survival.
    Corradi G; Baldazzi C; Očadlíková D; Marconi G; Parisi S; Testoni N; Finelli C; Cavo M; Curti A; Ciciarello M
    Stem Cell Res Ther; 2018 Oct; 9(1):271. PubMed ID: 30359303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia.
    Xia B; Tian C; Guo S; Zhang L; Zhao D; Qu F; Zhao W; Wang Y; Wu X; Da W; Wei S; Zhang Y
    Leuk Res; 2015 Jan; 39(1):92-9. PubMed ID: 25443862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stromal cells from patients with acute myeloid leukemia have altered capacity to expand differentiated hematopoietic progenitors.
    Chandran P; Le Y; Li Y; Sabloff M; Mehic J; Rosu-Myles M; Allan DS
    Leuk Res; 2015 Apr; 39(4):486-93. PubMed ID: 25703353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia.
    Takam Kamga P; Bassi G; Cassaro A; Midolo M; Di Trapani M; Gatti A; Carusone R; Resci F; Perbellini O; Gottardi M; Bonifacio M; Nwabo Kamdje AH; Ambrosetti A; Krampera M
    Oncotarget; 2016 Apr; 7(16):21713-27. PubMed ID: 26967055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.